uconn health

Methods to Reduce Animal Numbers

General Information

Federal laws and Institutional policies require us to apply the principles of the 3Rs (replacement, reduction, and refinement) to animal research. U.S. Government Principle #3 states “The animals selected for a procedure should be of an appropriate species and quality and the minimum number required to obtain valid results.” PHS policy states that the institution provide “training or instruction in research or testing methods that minimize the number of animals required to obtain valid results and minimize animal distress, offered to scientists, animal technicians, and other personnel involved in animal care, treatment, or use.” The Animal Welfare Regulations state that the institution must include training in “The concept, availability, and use of research or testing methods that limit the use of animals or minimize animal distress.”

Reduction is desirable in any procedure, however directly humane, which employs large numbers of animals. Reduction is of great importance and, of all modes of progress on the three Rs, it is the one most obviously, immediately, and universally advantageous in terms of efficiency. One general way in which great reduction may occur is by the right choice of strategies in the planning and performance of whole lines of research. Many investigators settle early in their research career on some strategy that appears to suit them and are liable never to change from that strategy.

The term Reduction Alternatives describes methods for obtaining comparable levels of scientific procedures or for obtaining more information from a given number of animals. Proper statistical design is essential. The precision of an experiment depends mainly on the sample size and error variance. Careful attention must be given to the type of endpoint used. Qualitative endpoints (e.g., dead/alive) often involve severe pain and distress and generally provide less information than quantitative measurements. There is evidence that poor experimental design and inappropriate statistical analysis has lead to the inefficient use of animals. This may be due to a low level of statistical expertise in the investigators so that they are unaware of the potential value of obtaining statistical advise. Alternatively, they may be unable to do so because of a lack of qualified biometricians with experience in their field of interest. In a research project by Hume (1957), he showed that every time any particle of statistical method is properly used, fewer animals are employed than would otherwise have been necessary.

Common Methods to Reduce Animal Numbers

Power Analysis

Statistical significance and biological significance are not the same thing; however, statistical and biological significance can be linked through the use of statistical power analysis. The statistical power of a test is the probability of getting a statistically significant result, given that the null hypothesis is false. Power is proportional to the sample size, significance criterion and effect size, and is inversely proportional to the variance in the population. Effect size is a measure of biological significance: it is the difference between the results predicted by the null hypothesis and the actual state of the population being tested. Power analysis can be used to determine whether the experiment has a good chance of producing a statistically significant result if a biologically significant difference exists in the population. Or, in other words, whether the experiment has a high power, given a biologically significant effect size. What constitutes “high power” is best left to the researcher, but conventions of 0.8 and 0.95 have been suggested in the literature. It is beyond the scope of this general introduction to teach statistics to the researchers, but there are methods that are out there that are available. Consultation with a biostatistician can yield benefits to the PI and the experimental animals.

Pilot Studies

Pilot studies are a good way to reduce the number of animal used; the IACUC may even require a pilot study when reviewing a protocol. Pilot studies can be used to estimate variability and evaluate procedures and effects.

Appropriate Use of Endpoints

The precision of an experiment depends mainly on the sample size and error variance. Careful attention must be given to the type of endpoint used. Qualitative endpoints (e.g., dead/alive) often involve severe pain and distress and generally provide less information than quantitative measurements. More information can generally be found using quantitative endpoints and can, in some instances, lead to a reduction in the number of animals used during an experiment.

Sharing Animals

In some instances, it is possible to share research animals. For instance, animals euthanized by one investigator can provide tissue for use by another investigator. There are instances in which this should never be attempted (e.g., animals have been exposed to biological hazards, chemical hazards, and/or recombinant DNA), but it is a method to reduce animal numbers that should be explored by researchers.

Use Quality Animals and Veterinary Care

When PIs use the correct choice of an animal model- one that uses healthy, genetically similar animals- it generally decreases variability and, hence, animal numbers. You can minimize the loss of animals by providing good post-operative care, avoiding unintended breeding, and planning ahead so that the appropriate number of animals needed for the studies are ordered and/or bred.

Computer Simulations

Though not always possible, there are cases in which there are computer simulations available which can mimic functions of physiology. These are typically most helpful in the case of training protocols.

Use of Cell Culture

When possible, consider the use of cell cultures rather than animals. For example, there are in vitro systems which use cell culture to generate monoclonal antibodies rather than using laboratory animals.

Auto Controls

It would be helpful, whenever possible, to design experiments in which animals serve as their own control. For example, if a procedure were to be performed on a limb, instead of doing the procedure on both limbs of an animal- and having separate control animals- do a unilateral procedure with the control being the opposite limb. Though this is not always possible, it is a well-established method for reducing animal numbers.

New Instrumentation and Techniques

Using new instrumentation or innovative techniques that can improve precision can reduce the number of animals needed for a study. This has the added benefit of also being a refinement technique for the protocol.

Appropriate Experimental Design

Careful experimental design by appropriate choice of control groups and standardizing procedures to minimize variability; for example, University of Leicester researchers designed experiments to reduce the number of mice required to investigate treatment combinations in a study of tumors resulting in an average of 1.5 mice per treatment combination instead of the 20 to 40 mice per treatment combination usually used.

Ethics of Animal Use

This issues of animals and ethics and the use of animals in biomedical research are ones that are important for all researchers and personnel who use animals to take some time to think about. It is not the intent of the IACUC to tell you how you should feel about this topic; however, it is important that information be available to the research and animal care community so that each individual can explore these topics.
In 1996, NASA published an influential document titled “NASA Principles for the Ethical Care and Use of Animals”.  It was intended to guide careful and considered discussion of the ethical challenges that arise in the course of animal research under NASA’s auspices, but it is helpful to animal use in general.  Briefly stated, the document states that a strong allegiance to the principles of bioethics is vital to responsible research practices and that vertebrate animals warrant moral concern.  The use of animals in research involves responsibility – not only for the stewardship of the animals, but to the scientific community and society as well.  The three basic principles of the document include:
  1. Respect for Life.  This principle requires that animals used n research should be of an appropriate species and health status and should involve the minimum number required to obtain valid scientific results.  It also recognizes that the use of different species may raise different ethical concerns.
  2. Societal Benefit.  This principle entails that where animals are used, the assessment of the overall ethical value of such use should include consideration of the full range of potential societal good, the populations affected, and the burdens that are expected to be borne by the subjects of the research.
  3. Non-maleficence.  This principle entails that the minimization of distress, pain, and suffering is a moral imperative.  Unless the contrary is established, investigators should consider that procedures that cause pain or distress in humans may cause pain or distress in other sentient animals.

Occupational Health and Safety

Institutions that receive federal funding to conduct animal research must provide an occupational health program for individuals who work with animals. This is a requirement of the Public Health Service Policy on Humane Care and Use of Laboratory Animals. Workers who work with laboratory animals must be enrolled in the program not on the basis of contact hours or job title, but on the basis of risk associated with the work they perform.

 

Helpful Links

 

Assessing Risks

We’ve provided a Risk Assessment Analysis to help give you the information you need to be safe on the job. Click on the animal(s) that you work with to see a risk assessment typically associated with that species. Please note that this is intended to supplement, not replace, information and advice you may receive from Employee Health Services, Environmental Health and Safety, or the Biosafety Officer nor is it intended to be a complete risk assessment. This is a starting point only. Please contact Employee Health Services for information specific to your personal situation. Everyone should be provided the safest work environment possible.

 

Information

 

What You Need to Know When Working with Laboratory Animals

 

Cercopithecine Herpesvirus 1 (Herpes B Virus) Links

Reference Books

Office of Clinical & Translational Research

The Office of Clinical and Translational Research (OCTR) website has been compiled to assist the principal investigator (PI), research staff and sponsors to navigate the intricacies of budget and contract negotiations as well as the complexities of research financial compliance.

Our mission is to ensure that investigators who carry out clinical trials/research at UConn Health adhere to federal and state laws/regulations and institutional policies that govern clinical trials/research contract negotiations and define research financial compliance.

Staff in the OCTR provides researchers the fiscal and contractual administrative support necessary to conduct clinical trials/research within the institution and community. The goals of the OCTR are to:

  • Work collaboratively with researchers to develop viable clinical trial/research budgets for all protocols opened at UConn Health
  • Create a Budget Workbook for each clinical trial or clinical research study done at UConn Health that accrues John Dempsey Hospital (JDH) and/or UConn Medical Group (UMG) and/or dental medicine charges
  • Negotiate clinical trial or clinical research budgets with the sponsor
  • Negotiate all contracts for:
    • Non-federal investigator initiated industry supported clinical trials
    • Industry sponsored clinical trials
    • University to university clinical trials
    • Co-operative group clinical trials
    • Foundation supported clinical trials
  • Establish Banner research accounts and reconcile these accounts to actual charges
  • Audit ongoing clinical trials or clinical research to assure research financial compliance with institutional policies and state and federal laws/regulations

If you have any questions regarding the services provided by the staff in the OCTR, or you would like to set up an appointment to discuss services, please call us at 860-679-4040.

Financial Conflict of Interest

The Financial Conflict of Interest in Research program supports the UConn Health research community with understanding and complying with University requirements related to financial conflicts of interest (FCOIs) in research.

Who is an Investigator?

  • Investigator means the project director or Principal Investigator (PI) and any other person, regardless of title or position, who is responsible for the design, conduct, or reporting of research (regardless of sponsor or funding source), which may include, for example, collaborators or consultants.

What are my responsibilities as a UConn Health investigator?

  • Review and be knowledgeable of the UConn Health policy on financial conflicts of interest in research, including the definition of Significant Financial Interest (SFI) and how it applies to you.
  • Promptly and fully disclose all SFIs, including those of a spouse and/or dependent child, that reasonably relate to your institutional responsibilities; and, if applicable, comply with FCOI management or mitigation plans.
  • Submit a financial disclosure in the UConn Health InfoEd Financial Interests [FCOI] system: https://uchealth.infoed.uconn.edu.
    • Annually
    • Within 30 days of acquiring or discovering a new SFI
    • Investigators on PHS awards or other sponsored projects requiring adherence to PHS FCOI regulations: Within 30 days of any applicable reimbursed or sponsored travel
  • Understand that completion and submission of the financial disclosure form also satisfies the FCOI training requirement, as required under federal regulations and UConn Health policy.
  • Investigators, coordinators, and persons obtaining consent must also disclose any project-specific SFIs pursuant to UConn Health Human Subject Protection Program (HSPP) policies.

What other resources are available to help investigators?

Biosafety for Research (& IBC)

biohazard
To get a general idea of compliance requirements for different areas of research, here is a Regulatory Overview for researchers.

The goal of UConn Health Biosafety website is to make understanding the requirements more convenient and to provide information and resources to help our community members perform their work in safe and healthy ways that promote productive, legal science with as little/ few fuss, fines or imprisonment (FFI) as possible on anyone’s part.

The UConn Health Biosafety Program has safety and regulatory requirements involving the following research situations:

If you have questions, suggestions or concerns about the Biosafety Program or this website please contact:

Biological Safety Officer: TBD

Biosafety Program Coordinator: Victoria Scranton, vscranton@uchc.edu 860.679.7533

or email to ibc@uchc.edu.

 

Center for Comparative Medicine

AAALAC Accredited

The Center for Comparative Medicine (CCM) at UConn Health is committed to ensure humane and ethical care and use of animals involved in approved research to advance medical, biomedical and veterinary knowledge for the benefit of all. The CCM is an AAALAC International accredited facility, provides quality animal care to meet or exceed the standards and policies of Public Health, Animal Welfare Act PL 89-544 (1966) and subsequent amendments and the documents entitled “Guide for the Care and Use of Laboratory Animals” and “Public Health Service Policy on Humane Care and Use of Laboratory Animals.”

Comparative Medicine Services » [Restricted by IP Address, Secure Login Required]

We are here to help! You can contact any of my team members or me directly and I’d be happy to assist you.

Ramaswamy M. Chidambaram, D.V.M., Ph.D., DACLAM
Director, Center for Comparative Medicine
Phone: 860-679-2731
Fax: 860-679-1300
Email: clac@uchc.edu

Research Integrity & Compliance

The University of Connecticut and UConn Health are committed to the highest standards of integrity in fulfilling its mission to expand human knowledge and benefit society through research. All research activities undertaken by faculty, staff, and students at UConn will be conducted in accordance with strict ethical principles and in compliance with federal, state, and institutional regulations and policies. Research Integrity & Compliance (RIC) reports to the Vice President for Research, Innovation and Entrepreneurship. RIC is responsible for providing support and training to faculty, students and staff in order to meet these requirements and maintain a robust research compliance program at UConn Health.

RIC works with the faculty oversight committees to promote the ethical and responsible conduct of research and to ensure compliance with regulatory requirements relating to research including:

Environmental Health and Safety

Mission

Environmental Health and Safety is a group of highly-skilled specialists dedicated to promoting a healthy and safe work environment, for the UConn Health community. We are dedicated to the health, safety and welfare of our research, medical, dental and support communities in the fields of environmental, biological, chemical and radiation safety. Our directive includes but is not limited to; fostering a safety culture, compliance alignment strategies strengthened by audits, providing comprehensive trainings in a variety of disciplines, risk reduction techniques, environmental stewardship, workplace evaluations, proper waste disposal oversite, injury and accident mitigation efforts. Environmental Health and Safety’s dedicated team of professionals is uniquely positioned to provide comprehensive EH&S services to the aforementioned, in support of UConn Health’s mission of excellence in research, teaching, service, and community outreach.

 

Vision

To promote and maintain a safe and healthful environment by ensuring the highest level of environmental health and safety services, achieved via departmental partnerships, leadership support and collaboration with faculty, staff, students, and visitors at UConn Health.

 

Goals

  • EH&S develops and administers comprehensive programs and services with the goal of establishing sustainable and effective safety compliance.
  • Ensuring all written guidance documents, procedures, and training materials are created and appropriately aligned to applicable regulatory standards; are current and disseminated accordingly.
  • Providing high quality and efficient services in support of biological, chemical, environmental and radiological safety.

Awards

In addition to being UConn Health’s authorized representative for grants, contracts and other agreements from government agencies, private industry, and non-profit foundations and the central point of coordination for sponsored projects, Sponsored Program Services administers grants and contracts on behalf of UConn Health.

Activities include establishing new awards and budgets in the UConn Health’s accounting system (Banner) and assisting with pre-award coding requests, approving and processing re-budgets of expenditures, cost transfers, no-cost extensions and preparation of final financial reports.Awards Management also provides guidance and consultation on issues such as applicable regulations, allowable costs, cost share and match requirements as well as monitoring account activity for adherence to terms and conditions of awards and applicable policies and regulations.All grant management policies at UConn Health are derived from Federal, State and University policies and regulations such as Office of Management and Budget Uniform Grant Guidance.